background

RETHINKING THE MOUNTAIN CEDAR (ASHE JUNIPER)


Soils in the Hill Country of Texas have been subjected to numerous severe disturbances over the last 150 years. If Mountain Cedars hadn't morphed from trees in forests and woodlands into pioneering thickets of bushy-cedars, our soils would be much more degraded today.

mountaincedars.com

Copyright © 2021 Elizabeth McGreevy

3713 Counselor Drive, Ste. 104


wantedmountaincedars@gmail.com

Tel: 512-657-9675

Tuesday through Friday, 1:00 to 6:00 pm



Website Building Application

Medicinal

Research of potential uses of Juniper trees

Ara R. and N. Misra, 1992. “Antifungal activity of mixture of essential oils against some dermato-types,” Indian Perfumer. Volume 36, 38-41.


Arora R.B., S. Roy, and S.U. Khan. 1986. “Role of elements in pathophysiology of hypertension and antihypertensive drug development,” Acta Pharmocologica et Toxicologica. Volume 59, 344-347.


Bais S., N. Abrol N, Y. Prashar, R. and Kumari, 2017. “Modulatory effect of standardised amentoflavone isolated from Juniperus communis L. against Freund's adjuvant induced arthritis in rats (histopathological and X Ray analysis),” Biomed Pharmacother. Volume 86:381-392.


Benzina Sami, Jason Harquail, Stephanie Jean, Annie-Pier Beauregard, Caitlyn D Colquhoun, Madison Carroll, Allyson Bos, Christopher A Gray, and Gilles A Robichaud, 2015. “Deoxypodophyllotoxin isolated from Juniperus communis induces apoptosis in breast cancer cells,” Anticancer Agents Med Chem. Volume 15(1):79-88.


Cairnes D.A., O.E. Kundayo, and G.I. Kingston, 1980. “Plant anticancer agents. X. Lignins from Juniperus phoenicea,” J. Nat. Prod. Volume 43: 495-497.


Cavaleiro C., E. Pinto, M.J. Gonçalves, and L. Salgueiro, 2006. “Antifungal activity of Juniperus essential oils against dermatophyte, Aspergillus and Candida strains,” J Appl Microbiol. Volume 100(6):1333-1338.


Fernandez, Alejandra, and Ian Edwin Cock, 2016. “The Therapeutic Properties of Juniperus communis L.: Antioxidant Capacity, Bacterial growth Inhibition, Anticancer Activity and Toxicity,” Pharmacognosy Journal. Volume 8(3): 273-280.


Gumral N., D.D. Kumbul, F. Aylak, M. Saygin, and E. Savik, 2015. “Juniperus communis Linn oil decreases oxidative stress and increases antioxidant enzymes in the heart of rats administered a diet rich in cholesterol,” Toxicol Ind Health. Volume 31(1):85-91.


Hartwell J.L., J.J. Johnson, D.B. Fitzgerald, and M. Belkin M,1953. “Podophyllotoxin from Juniperus species: Savinin,” JA Chem Soc. Volume 75:235–236.


Hernandez E.J., R. Villanova, and E. Canas, 1987. “Studies on the relaxant effects in smooth fibers of isolated rat uterus induced by oxygen-containing and oxygen-free terpenes,” Ars. Pharm. Volume 28, 213-225.


Kagawa, Daiji, Hiroko Jokura, Ryuji Ochiai, Ichiro Tokimitsu, and Hirokazu Tsubone, 2003. “The sedative effects and mechanism of action of cedrol inhalation with behavioral pharmacological evaluation,” Plant Med. Volume 69(7): 637-641.


Karchesy, J., 1998. The Literature of Juniper Utilization for Oils and Specialty Products: A Report to the Western Juniper Steering Committee. Department of Forest Products. Oregon State University.


Komori, T., T. Matsumoto, M. Yamamoto, E. Motomura, T. Shiroyama, and Y. Okazaki, 2005. “Application of Fragrance in Discontinuing the Long-Term Use of Hypnotic Benzodiazepines,” International Journal of Aromatherapy. Volume 16(1): 3-7.


Kupchan M., J.C. Hemingway, and J.R. Knox, 1966. “Tumor inhibitors VII. Podophyllotoxin, the active principle of Juniperus virginiana,” J. Pharm. Science. 659-660.


McChesney J.D. and R.P. Adam, 1985. “Co-evaluation of plant extracts as petrochemical substitutes and for biologically active compounds,” Economic Botany. Volume 39, 74-86.


Sanchez de Medina F, Gamez MJ, Jimenez I, Jimenez J, Osuna JI, and Zarzuelo A., 1994. “Hypoglycemic activity of juniper berries,” Planta Med. Volume 60:197-200.


Zhao, Jun, Tao Liu, Fang Xu, Shuping You, Chenyang Li, and Zhengyi Gu, 2016. “Anti-arthritic Effects of Total Flavonoids from Juniperus sabina on Complete Freund's Adjuvant Induced Arthritis in Rats,” Pharmacognosy Magazine. Volume 12(47): 178-183.